YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
(RTTNews) - Today's top biotech gainers include Trinity Biotech, which recently completed reverse split; OPKO Health, driven by its second-quarter financial results and continued pipeline progress; Kiniksa Pharma, after raising its revenue…
Investing.com - U.S. stock futures were mixed on Tuesday as renewed concerns over artificial intelligence spending weighed on semiconductor stocks ahead of a pivotal week featuring mega-cap technology earnings and the Federal Reserve's lat…
No ARIA-E observed across all genotypes, including APOE4 homozygotes ARIA-H tracking background rates Early biomarker movement consistent with target engagement 12-month topline results expected in Q1 2027 Cambridge, Massachusetts, July 28…
The Cigna Group CI is set to report second-quarter 2026 results on July 30, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $7.58 per share on revenues of $71.4 billion…
Hospital operator Universal Health Services, Inc. UHS is set to report second-quarter 2026 results on July 27, 2026, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $5.6…
Hospital operator Tenet Healthcare Corporation THC is set to report second-quarter 2026 results on July 24, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $4.08…
Hospital operator HCA Healthcare, Inc. HCA is set to report second-quarter 2026 results on July 24, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $7.41 per shar…
Molina Healthcare, Inc. MOH is set to report its second-quarter 2026 results on July 22, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $1.37 per share on revenues of $…
Community Health Systems, Inc. CYH is set to report second-quarter 2026 results on July 22, 2026, after the closing bell. The bottom-line estimate is currently pegged at a loss of 18 cents per share on revenues of $2.9 billion. The second-…
(RTTNews) - ProMIS Neurosciences Inc. (PMN), a clinical-stage biotechnology company, reported the first human evidence that its lead Alzheimer's drug candidate, PMN310, can reduce toxic amyloid-beta oligomers in cerebrospinal fluid. The fi…
(RTTNews) - ProMIS Neurosciences Inc. (PMN) said on Tuesday that its lead Alzheimer's disease drug candidate, PMN310, demonstrated the first human evidence of a dose-dependent reduction in amyloid-beta oligomers, which are widely considere…
PMN310 demonstrated dose-dependent reduction of amyloid-beta oligomers in human cerebrospinal fluid following a single dose in healthy volunteers Represents one of the first quantitative measures of treatment-related effects on oligomer le…
Elevance Health, Inc. ELV is set to report its second-quarter 2026 results on July 15, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $6.18 per shareon revenues…
(RTTNews) - Today's top gainers in the biotech space include Cuprina, which recently received FDA clearance for its maggot-based wound treatment; ABIVAX, following encouraging results from an ulcerative colitis study; ProMIS, which has a k…
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseas…
As European markets experience a positive momentum, with the pan-European STOXX Europe 600 Index climbing 3.00% amid hopes for geopolitical de-escalation, investors are increasingly focusing on dividend stocks as a means to navigate econom…
Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from long-term global investors. Proceeds are expected to fund the Company through 2027, including completion of the ongo…
As European markets experience a positive upswing, with the STOXX Europe 600 Index rising by 1.91% amid easing geopolitical tensions and steady corporate earnings, investors are increasingly looking to dividend stocks as a reliable income…
* ProMIS Neurosciences press release [https://seekingalpha.com/pr/20450565-promis-neurosciences-announces-full-year-2025-financial-results-and-provides-corporate] (PMN [https://seekingalpha.com/symbol/PMN]): FY GAAP EPS of -$22.61 misses b…
Quick Read Soho House (SHCO) saw a $100M insider purchase as it completed its merger with MCR Hospitality Fund IV. W.R. Berkley attracted $57M in sustained insider buying despite quarterly earnings declining 21.7% year-over-year. Sonos ins…
As the European market shows resilience with the pan-European STOXX Europe 600 Index rising by 0.77%, investors are keenly observing economic data and earnings results that continue to shape market sentiment. In this environment, selecting…
(RTTNews) - Several small-cap biotech and healthcare names posted notable gains in Thursday's after-hours trading session, with investors reacting to recent corporate updates and clinical milestones. Inspira Technologies Oxy B.H.N. Ltd. (I…
Large, well-powered Phase 1b study, designed to generate clinically and biologically meaningful insights in early Alzheimer’s disease Clear and near-term value inflection points, with blinded 6-month interim data expected in Q2 2026 and fi…
As the pan-European STOXX Europe 600 Index experienced a slight decline, with mixed performances across major stock indexes such as Germany's DAX and France's CAC 40, investors are closely watching the European Central Bank's potential pol…
(RTTNews) - Biotechnology stocks saw notable movement in after-hours trading on Monday, with several companies posting strong gains. Below is a structured look at the key movers and the developments driving their performance. Exicure, Inc.…
* ProMIS Neurosciences (PMN [https://seekingalpha.com/symbol/PMN]) plans to implement a one-for-twenty-five reverse stock split of the company’s common shares on November 28, 2025. * The reverse stock split is intended to increase the mark…
ProMIS Neurosciences Inc. Cambridge, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neuro…
Cambridge, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, to…
Appointment reinforces ProMIS Neurosciences’ strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer’s program, PMN310 Cambridge, Massachusetts, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosc…
As European markets navigate a complex landscape of monetary policy decisions, the pan-European STOXX Europe 600 Index recently ended the week slightly lower, reflecting mixed performances across major stock indexes. In this environment, d…
Cohort 2 fully enrolled; enrollment and dosing now underway for Cohort 3 (final dose level); No cases of amyloid-related imaging abnormalities (ARIA) observed to date; The trial, expected to enroll 128 patients, remains on track to report…
* ProMIS Neurosciences press release [https://seekingalpha.com/pr/20199117-promis-neurosciences-announces-second-quarter-2025-financial-results-and-corporate-highlights] (NASDAQ:PMN [https://seekingalpha.com/symbol/PMN]): Q2 GAAP EPS of -$…
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT HTOOW [https://www.chartmill.com/stock/…
TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 28, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to discovery and development of therapeutic antibodies targeting to…
In trading on Thursday, shares of CVB Financial Corp (Symbol: CVBF) crossed below their 200 day moving average of $20.01, changing hands as low as $19.75 per share. CVB Financial Corp shares are currently trading off about 5.6% on the day.…
Wedbush Securities downgraded Replimune Group (REPL) to neutral from outperform, while adjusting its PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…